Wu et al. [8] have shown using angiogenesis, ribonucleolysis, and nuclear translocation assays that ANG mutations identified in ALS patients are associated with functional loss of angiogenic activity. The gene discussed is ANG; the disease is amyotrophic lateral sclerosis.